|
CPSF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.355720E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.079200E-03 |
| Normal-vs-Stage2 |
6.241400E-01 |
| Normal-vs-Stage3 |
5.154800E-04 |
| Normal-vs-Stage4 |
8.139000000007E-05 |
| Stage1-vs-Stage2 |
3.050500E-02 |
| Stage1-vs-Stage3 |
3.449200E-01 |
| Stage1-vs-Stage4 |
7.962300E-02 |
| Stage2-vs-Stage3 |
1.302300E-02 |
| Stage2-vs-Stage4 |
5.118400E-03 |
| Stage3-vs-Stage4 |
3.378600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.751500E-04 |
| Normal-vs-AfricanAmerican |
3.990200E-01 |
| Normal-vs-Asian |
3.65800000000638E-05 |
| Caucasian-vs-AfricanAmerican |
1.373030E-01 |
| Caucasian-vs-Asian |
8.009700E-02 |
| AfricanAmerican-vs-Asian |
8.616100E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.608300E-04 |
| Normal-vs-Female |
3.782000E-03 |
| Male-vs-Female |
1.550580E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.319100E-03 |
| Normal-vs-Age(41-60Yrs) |
1.059950E-03 |
| Normal-vs-Age(61-80Yrs) |
1.053860E-02 |
| Normal-vs-Age(81-100Yrs) |
1.589370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.139800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.699000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.906400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.901800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.449600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.985800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.360810E-01 |
| Classical-VS-Follicular |
3.933400E-01 |
| Classical-VS-Other |
8.731500E-02 |
| Classical-VS-Normal |
2.539300E-03 |
| Tall-VS-Follicular |
5.834300E-02 |
| Tall-VS-Other |
3.375600E-01 |
| Tall-VS-Normal |
9.375500E-04 |
| Follicular-VS-Other |
1.140410E-01 |
| Follicular-VS-Normal |
8.879600E-02 |
| Other-VS-Normal |
4.541800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.396100E-03 |
| Normal-vs-N1 |
5.65489999999613E-05 |
| N0-vs-N1 |
2.872200E-02 |
|
|
